medmix AG (SWX:MEDX)
Switzerland · Delayed Price · Currency is CHF 8.92
+0.14 (1.59%)
Mar 12, 2026, 5:30 PM CET
medmix AG Cash Flow Statement
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 6.4 | -7.4 | 0.3 | 11.6 | 44 |
Depreciation & Amortization | 53.3 | 59.1 | 53 | 47.9 | 49.3 |
Other Amortization | 2.2 | 2.5 | 2.5 | 1.7 | 1.5 |
Loss (Gain) From Sale of Assets | -0.2 | -0.8 | - | - | -0.1 |
Asset Writedown & Restructuring Costs | - | - | 2.9 | 16.9 | 0.9 |
Loss (Gain) on Equity Investments | - | 5.7 | - | - | - |
Stock-Based Compensation | 3.1 | 4.4 | - | - | - |
Other Operating Activities | 1.7 | -11.9 | -0.8 | 17.1 | 5.2 |
Change in Accounts Receivable | -12.2 | 12.4 | 2 | -38.9 | -2.9 |
Change in Inventory | -2.7 | 17.8 | 0.4 | -29.2 | -18.9 |
Change in Accounts Payable | 5.7 | -7.2 | -3.3 | 10 | 12.1 |
Change in Unearned Revenue | 3.7 | -2.2 | 0.2 | -0.3 | -0.7 |
Change in Other Net Operating Assets | 6.8 | 14.2 | -1.1 | 10.8 | -3.1 |
Operating Cash Flow | 67.8 | 86.6 | 56.1 | 47.6 | 87.3 |
Operating Cash Flow Growth | -21.71% | 54.37% | 17.86% | -45.48% | 72.53% |
Capital Expenditures | -34.5 | -38.5 | -46.4 | -36.4 | -29.8 |
Sale of Property, Plant & Equipment | 0.4 | 1.5 | 0.2 | 1.3 | 0.2 |
Cash Acquisitions | - | -4.5 | -29.4 | -14.7 | -2.7 |
Divestitures | - | - | 4 | -2 | - |
Sale (Purchase) of Intangibles | -6.6 | -10 | -6.5 | -2.2 | -2.1 |
Investment in Securities | - | - | -2.4 | -3 | 31.2 |
Other Investing Activities | - | - | -0.1 | - | -0.1 |
Investing Cash Flow | -40.7 | -51.5 | -80.6 | -57 | -3.3 |
Short-Term Debt Issued | 23.5 | 16.4 | 33.6 | 310.5 | 107.6 |
Long-Term Debt Issued | - | - | - | - | 265.2 |
Total Debt Issued | 23.5 | 16.4 | 33.6 | 310.5 | 372.8 |
Short-Term Debt Repaid | -26.7 | -37.7 | -157.2 | -161.6 | -245.9 |
Long-Term Debt Repaid | -10.7 | -11.9 | -10.4 | -11.9 | -263.1 |
Total Debt Repaid | -37.4 | -49.6 | -167.6 | -173.5 | -509 |
Net Debt Issued (Repaid) | -13.9 | -33.2 | -134 | 137 | -136.2 |
Issuance of Common Stock | - | - | - | - | 294.7 |
Repurchase of Common Stock | -2.6 | -0.5 | -3.1 | -6.1 | -6.5 |
Common Dividends Paid | -15 | -15 | -15 | -15 | -41.3 |
Other Financing Activities | -4.8 | 0.1 | -1.7 | 0.2 | 0.9 |
Financing Cash Flow | -36.3 | -48.6 | -153.8 | 116.1 | 111.6 |
Foreign Exchange Rate Adjustments | -3.4 | 1 | -4.6 | -2.9 | -0.6 |
Miscellaneous Cash Flow Adjustments | - | - | - | -0.1 | - |
Net Cash Flow | -12.6 | -12.5 | -182.9 | 103.7 | 195 |
Free Cash Flow | 33.3 | 48.1 | 9.7 | 11.2 | 57.5 |
Free Cash Flow Growth | -30.77% | 395.88% | -13.39% | -80.52% | 576.47% |
Free Cash Flow Margin | 7.43% | 9.94% | 1.99% | 2.35% | 12.57% |
Free Cash Flow Per Share | 0.80 | 1.16 | 0.23 | 0.27 | 1.40 |
Cash Interest Paid | 13.8 | 12.7 | 6.3 | 6.5 | 8.1 |
Cash Income Tax Paid | 6.7 | 9.6 | 7.9 | 10.5 | 7.9 |
Levered Free Cash Flow | 30.94 | 62.44 | 33.26 | 5.54 | 73.69 |
Unlevered Free Cash Flow | 37.63 | 70 | 39.51 | 9.6 | 78.75 |
Change in Working Capital | 1.3 | 35 | -1.8 | -47.6 | -13.5 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.